3 completed. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Plasmids: new trials by email Literature Review of Plasmids trials Research Report on Plasmids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant - HIV Infections | Phase 1 | Completed | Worcester HIV Vaccine | 42 | 2021-07-08 | 2024-04-09 |
| Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, Placebo - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2018-03-16 | 2022-04-25 |
| Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma IL-12p DNA, Intratumoral Electroporation - Malignant Melanoma | Not applicable | Completed | H. Lee Moffitt Cancer Center and Research Institute | 24 | 2004-06-01 | 2017-02-23 |
HIV Infections (2) · Melanoma (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Worcester HIV Vaccine (1)
United States (3)
Adil Daud, MD (1) · Ian Frank (1) · Turner Overton (1)